Bristol-Myers Squibb Pharmaceuticals Group
Executive Summary
President-Central and Eastern Europe Joachim von Roy named president-Europe. He will continue to be based in Munich, reporting to Pharmaceutical Group President Kenneth Weg. In addition, von Roy assumes worldwide responsibility for BMS' cardiovascular product planning and becomes a member of group's operating committee. Samuel Hamad, president of the intercontinental division of the BMS Pharmaceutical Group, has assumed responsibility for Latin America and Japan in addition to his current responsibilities of Asia, Australia/New Zealand, Canada, the Middle East and Africa.